Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)
- PMID: 10854097
- DOI: 10.1038/sj.ejhg.5200470
Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)
Abstract
The R141H mutation in the PMM2 gene is the most frequent mutation in type Ia of the congenital disorders of glycosylation (formerly carbohydrate-deficient glycoprotein syndromes)(CDG-Ia). However, it has never been observed in the homozygous state. Homozygosity for this mutation is probably incompatible with life. In this study, we determined the frequency of R141H in two normal populations: in neonates of Dutch origin 1/79 were carriers, whilst in the Danish population, a carrier frequency of 1/60 was found. These figures are clearly in disequilibrium with the frequency of CDG-Ia that has been estimated at 1/80,000 to 1/40,000 in these populations. Haplotype analysis of 43 patients with the R141H mutation of different geographic origins indicated that the R141H is an old mutation in the Caucasian population. Based on the new data, the disease frequency has been calculated at 1/20,000 in these populations. It is concluded that the disease is probably underdiagnosed.
Similar articles
-
Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.Ann Hum Genet. 2007 May;71(Pt 3):348-53. doi: 10.1111/j.1469-1809.2006.00334.x. Epub 2006 Dec 12. Ann Hum Genet. 2007. PMID: 17166182
-
PMM2 intronic branch-site mutations in CDG-Ia.Mol Genet Metab. 2006 Apr;87(4):337-40. doi: 10.1016/j.ymgme.2005.10.015. Epub 2005 Dec 20. Mol Genet Metab. 2006. PMID: 16376131
-
Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.Hum Mutat. 1999 Dec;14(6):543-4. doi: 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S. Hum Mutat. 1999. PMID: 10571956
-
[Molecular diagnosis of congenital disorders of glycosylation].Ann Biol Clin (Paris). 2005 Mar-Apr;63(2):135-43. Ann Biol Clin (Paris). 2005. PMID: 15771971 Review. French.
-
[Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].Duodecim. 2016;132(3):253-9. Duodecim. 2016. PMID: 26951030 Review. Finnish.
Cited by
-
Congenital disorders of glycosylation: Prevalence, incidence and mutational spectrum in the Polish population.Mol Genet Metab Rep. 2021 Feb 11;27:100726. doi: 10.1016/j.ymgmr.2021.100726. eCollection 2021 Jun. Mol Genet Metab Rep. 2021. PMID: 33643843 Free PMC article.
-
Evolutionary history and functional diversification of phosphomannomutase genes.J Mol Evol. 2010 Aug;71(2):119-27. doi: 10.1007/s00239-010-9368-5. Epub 2010 Jul 27. J Mol Evol. 2010. PMID: 20661555
-
Revisiting the immunopathology of congenital disorders of glycosylation: an updated review.Front Immunol. 2024 Mar 14;15:1350101. doi: 10.3389/fimmu.2024.1350101. eCollection 2024. Front Immunol. 2024. PMID: 38550576 Free PMC article. Review.
-
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2.PLoS One. 2015 Oct 21;10(10):e0139882. doi: 10.1371/journal.pone.0139882. eCollection 2015. PLoS One. 2015. PMID: 26488408 Free PMC article.
-
Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.G3 (Bethesda). 2019 Feb 7;9(2):413-423. doi: 10.1534/g3.118.200934. G3 (Bethesda). 2019. PMID: 30530630 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
